Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Interaction analysis and prioritization of mobile content
Radio communication system, base station apparatus, terminal apparatus, and radio communication method for radio communication system
Methods for non-linear image blending, adjustment and display
Representations of compressed video
Mask blank, transfer mask, and film denseness evaluation method
Method for fabricating solar cell
Method and apparatus for allocating erasure coded data to disk storage
  Randomly Featured Patents
Method for forming an electrode layer by a laser flow technique
Magnetic disc device having copy protect function
Adhesive film
Method and system for controlling power in a chip through a power-performance monitor and control unit
Filter underdrain system for backwash flow and method for measuring same
Automotive fuel pump impeller with staggered vanes
Packaging ampule
Light source lens
Automatically switched redundant switch configurations
Backup power system